nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—CHRM2—Dimenhydrinate—atopic dermatitis	0.408	0.672	CbGbCtD
Glycopyrrolate—CHRM2—Diphenhydramine—atopic dermatitis	0.199	0.328	CbGbCtD
Glycopyrrolate—Insomnia—Tacrolimus—atopic dermatitis	0.000434	0.00122	CcSEcCtD
Glycopyrrolate—Asthenia—Mometasone—atopic dermatitis	0.000433	0.00121	CcSEcCtD
Glycopyrrolate—Irritability—Prednisone—atopic dermatitis	0.000433	0.00121	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Prednisone—atopic dermatitis	0.000431	0.00121	CcSEcCtD
Glycopyrrolate—Mood swings—Prednisone—atopic dermatitis	0.000429	0.0012	CcSEcCtD
Glycopyrrolate—Somnolence—Tacrolimus—atopic dermatitis	0.000427	0.0012	CcSEcCtD
Glycopyrrolate—Pruritus—Mometasone—atopic dermatitis	0.000427	0.0012	CcSEcCtD
Glycopyrrolate—Sweating—Methylprednisolone—atopic dermatitis	0.000423	0.00119	CcSEcCtD
Glycopyrrolate—Dyspepsia—Tacrolimus—atopic dermatitis	0.000422	0.00118	CcSEcCtD
Glycopyrrolate—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000418	0.00117	CcSEcCtD
Glycopyrrolate—Nausea—Loratadine—atopic dermatitis	0.000417	0.00117	CcSEcCtD
Glycopyrrolate—Epistaxis—Triamcinolone—atopic dermatitis	0.000417	0.00117	CcSEcCtD
Glycopyrrolate—Dry skin—Prednisone—atopic dermatitis	0.000415	0.00117	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000414	0.00116	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000414	0.00116	CcSEcCtD
Glycopyrrolate—Fatigue—Tacrolimus—atopic dermatitis	0.000414	0.00116	CcSEcCtD
Glycopyrrolate—Pain—Tacrolimus—atopic dermatitis	0.00041	0.00115	CcSEcCtD
Glycopyrrolate—Constipation—Tacrolimus—atopic dermatitis	0.00041	0.00115	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Betamethasone—atopic dermatitis	0.000406	0.00114	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Dexamethasone—atopic dermatitis	0.000406	0.00114	CcSEcCtD
Glycopyrrolate—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000401	0.00113	CcSEcCtD
Glycopyrrolate—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000398	0.00112	CcSEcCtD
Glycopyrrolate—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000398	0.00112	CcSEcCtD
Glycopyrrolate—Rhinitis—Triamcinolone—atopic dermatitis	0.000398	0.00112	CcSEcCtD
Glycopyrrolate—Rhinitis—Methylprednisolone—atopic dermatitis	0.000397	0.00111	CcSEcCtD
Glycopyrrolate—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000396	0.00111	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000395	0.00111	CcSEcCtD
Glycopyrrolate—Abdominal distension—Prednisone—atopic dermatitis	0.000394	0.00111	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000392	0.0011	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000389	0.00109	CcSEcCtD
Glycopyrrolate—Vomiting—Mometasone—atopic dermatitis	0.000383	0.00108	CcSEcCtD
Glycopyrrolate—Urticaria—Tacrolimus—atopic dermatitis	0.000381	0.00107	CcSEcCtD
Glycopyrrolate—Rash—Mometasone—atopic dermatitis	0.00038	0.00107	CcSEcCtD
Glycopyrrolate—Dermatitis—Mometasone—atopic dermatitis	0.00038	0.00107	CcSEcCtD
Glycopyrrolate—Abdominal pain—Tacrolimus—atopic dermatitis	0.000379	0.00106	CcSEcCtD
Glycopyrrolate—Body temperature increased—Tacrolimus—atopic dermatitis	0.000379	0.00106	CcSEcCtD
Glycopyrrolate—Headache—Mometasone—atopic dermatitis	0.000378	0.00106	CcSEcCtD
Glycopyrrolate—Erythema—Prednisolone—atopic dermatitis	0.000376	0.00105	CcSEcCtD
Glycopyrrolate—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000375	0.00105	CcSEcCtD
Glycopyrrolate—Mental disorder—Hydrocortisone—atopic dermatitis	0.000369	0.00104	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000367	0.00103	CcSEcCtD
Glycopyrrolate—Malnutrition—Hydrocortisone—atopic dermatitis	0.000367	0.00103	CcSEcCtD
Glycopyrrolate—Erythema—Hydrocortisone—atopic dermatitis	0.000367	0.00103	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Prednisone—atopic dermatitis	0.000361	0.00101	CcSEcCtD
Glycopyrrolate—Nausea—Mometasone—atopic dermatitis	0.000358	0.001	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000357	0.001	CcSEcCtD
Glycopyrrolate—Vision blurred—Prednisolone—atopic dermatitis	0.000354	0.000993	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000354	0.000992	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Prednisone—atopic dermatitis	0.000353	0.000991	CcSEcCtD
Glycopyrrolate—Mental disorder—Methylprednisolone—atopic dermatitis	0.000347	0.000973	CcSEcCtD
Glycopyrrolate—Erythema—Triamcinolone—atopic dermatitis	0.000345	0.000969	CcSEcCtD
Glycopyrrolate—Malnutrition—Methylprednisolone—atopic dermatitis	0.000345	0.000967	CcSEcCtD
Glycopyrrolate—Erythema—Methylprednisolone—atopic dermatitis	0.000345	0.000967	CcSEcCtD
Glycopyrrolate—Asthenia—Tacrolimus—atopic dermatitis	0.000344	0.000966	CcSEcCtD
Glycopyrrolate—Pruritus—Tacrolimus—atopic dermatitis	0.000339	0.000952	CcSEcCtD
Glycopyrrolate—Dysgeusia—Triamcinolone—atopic dermatitis	0.000338	0.000949	CcSEcCtD
Glycopyrrolate—Convulsion—Prednisolone—atopic dermatitis	0.000325	0.000913	CcSEcCtD
Glycopyrrolate—Hypertension—Prednisolone—atopic dermatitis	0.000324	0.00091	CcSEcCtD
Glycopyrrolate—Convulsion—Hydrocortisone—atopic dermatitis	0.000318	0.000891	CcSEcCtD
Glycopyrrolate—Dizziness—Tacrolimus—atopic dermatitis	0.000317	0.00089	CcSEcCtD
Glycopyrrolate—Hypertension—Hydrocortisone—atopic dermatitis	0.000317	0.000888	CcSEcCtD
Glycopyrrolate—Erythema—Betamethasone—atopic dermatitis	0.000313	0.000879	CcSEcCtD
Glycopyrrolate—Erythema—Dexamethasone—atopic dermatitis	0.000313	0.000879	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.00031	0.00087	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Prednisone—atopic dermatitis	0.000308	0.000864	CcSEcCtD
Glycopyrrolate—Oedema—Prednisolone—atopic dermatitis	0.000306	0.00086	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000306	0.00086	CcSEcCtD
Glycopyrrolate—Vomiting—Tacrolimus—atopic dermatitis	0.000305	0.000856	CcSEcCtD
Glycopyrrolate—Rash—Tacrolimus—atopic dermatitis	0.000303	0.000849	CcSEcCtD
Glycopyrrolate—Dermatitis—Tacrolimus—atopic dermatitis	0.000302	0.000848	CcSEcCtD
Glycopyrrolate—Headache—Tacrolimus—atopic dermatitis	0.000301	0.000843	CcSEcCtD
Glycopyrrolate—Oedema—Hydrocortisone—atopic dermatitis	0.000299	0.00084	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000299	0.00084	CcSEcCtD
Glycopyrrolate—Convulsion—Triamcinolone—atopic dermatitis	0.000299	0.000839	CcSEcCtD
Glycopyrrolate—Tachycardia—Prednisolone—atopic dermatitis	0.000299	0.000839	CcSEcCtD
Glycopyrrolate—Convulsion—Methylprednisolone—atopic dermatitis	0.000299	0.000837	CcSEcCtD
Glycopyrrolate—Hypertension—Triamcinolone—atopic dermatitis	0.000298	0.000836	CcSEcCtD
Glycopyrrolate—Hypertension—Methylprednisolone—atopic dermatitis	0.000298	0.000835	CcSEcCtD
Glycopyrrolate—Infection—Hydrocortisone—atopic dermatitis	0.000297	0.000834	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000296	0.000831	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000294	0.000823	CcSEcCtD
Glycopyrrolate—Tachycardia—Hydrocortisone—atopic dermatitis	0.000292	0.00082	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000291	0.000817	CcSEcCtD
Glycopyrrolate—Flushing—Prednisone—atopic dermatitis	0.000291	0.000816	CcSEcCtD
Glycopyrrolate—Skin disorder—Hydrocortisone—atopic dermatitis	0.000291	0.000816	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000289	0.000812	CcSEcCtD
Glycopyrrolate—Dry mouth—Triamcinolone—atopic dermatitis	0.000288	0.000807	CcSEcCtD
Glycopyrrolate—Nausea—Tacrolimus—atopic dermatitis	0.000285	0.0008	CcSEcCtD
Glycopyrrolate—Confusional state—Methylprednisolone—atopic dermatitis	0.000284	0.000795	CcSEcCtD
Glycopyrrolate—Oedema—Triamcinolone—atopic dermatitis	0.000282	0.000791	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000282	0.000791	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000281	0.000789	CcSEcCtD
Glycopyrrolate—Infection—Triamcinolone—atopic dermatitis	0.00028	0.000785	CcSEcCtD
Glycopyrrolate—Hypotension—Hydrocortisone—atopic dermatitis	0.00028	0.000785	CcSEcCtD
Glycopyrrolate—Infection—Methylprednisolone—atopic dermatitis	0.000279	0.000784	CcSEcCtD
Glycopyrrolate—Insomnia—Prednisolone—atopic dermatitis	0.000277	0.000778	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000276	0.000774	CcSEcCtD
Glycopyrrolate—Tachycardia—Triamcinolone—atopic dermatitis	0.000275	0.000772	CcSEcCtD
Glycopyrrolate—Mental disorder—Prednisone—atopic dermatitis	0.000275	0.00077	CcSEcCtD
Glycopyrrolate—Tachycardia—Methylprednisolone—atopic dermatitis	0.000274	0.00077	CcSEcCtD
Glycopyrrolate—Skin disorder—Methylprednisolone—atopic dermatitis	0.000273	0.000766	CcSEcCtD
Glycopyrrolate—Erythema—Prednisone—atopic dermatitis	0.000273	0.000765	CcSEcCtD
Glycopyrrolate—Malnutrition—Prednisone—atopic dermatitis	0.000273	0.000765	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000272	0.000764	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000272	0.000763	CcSEcCtD
Glycopyrrolate—Convulsion—Dexamethasone—atopic dermatitis	0.000272	0.000762	CcSEcCtD
Glycopyrrolate—Convulsion—Betamethasone—atopic dermatitis	0.000272	0.000762	CcSEcCtD
Glycopyrrolate—Insomnia—Hydrocortisone—atopic dermatitis	0.000271	0.000759	CcSEcCtD
Glycopyrrolate—Hypertension—Dexamethasone—atopic dermatitis	0.000271	0.000759	CcSEcCtD
Glycopyrrolate—Hypertension—Betamethasone—atopic dermatitis	0.000271	0.000759	CcSEcCtD
Glycopyrrolate—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000263	0.000739	CcSEcCtD
Glycopyrrolate—Hypotension—Methylprednisolone—atopic dermatitis	0.000263	0.000737	CcSEcCtD
Glycopyrrolate—Pain—Prednisolone—atopic dermatitis	0.000262	0.000735	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000258	0.000725	CcSEcCtD
Glycopyrrolate—Fatigue—Hydrocortisone—atopic dermatitis	0.000258	0.000724	CcSEcCtD
Glycopyrrolate—Vision blurred—Prednisone—atopic dermatitis	0.000257	0.000721	CcSEcCtD
Glycopyrrolate—Pain—Hydrocortisone—atopic dermatitis	0.000256	0.000718	CcSEcCtD
Glycopyrrolate—Oedema—Dexamethasone—atopic dermatitis	0.000256	0.000717	CcSEcCtD
Glycopyrrolate—Oedema—Betamethasone—atopic dermatitis	0.000256	0.000717	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000256	0.000717	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000256	0.000717	CcSEcCtD
Glycopyrrolate—Insomnia—Triamcinolone—atopic dermatitis	0.000255	0.000715	CcSEcCtD
Glycopyrrolate—Insomnia—Methylprednisolone—atopic dermatitis	0.000254	0.000714	CcSEcCtD
Glycopyrrolate—Infection—Dexamethasone—atopic dermatitis	0.000254	0.000713	CcSEcCtD
Glycopyrrolate—Infection—Betamethasone—atopic dermatitis	0.000254	0.000713	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Prednisolone—atopic dermatitis	0.000253	0.000708	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000251	0.000704	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Betamethasone—atopic dermatitis	0.000251	0.000704	CcSEcCtD
Glycopyrrolate—Agitation—Prednisone—atopic dermatitis	0.000251	0.000703	CcSEcCtD
Glycopyrrolate—Tachycardia—Betamethasone—atopic dermatitis	0.00025	0.0007	CcSEcCtD
Glycopyrrolate—Tachycardia—Dexamethasone—atopic dermatitis	0.00025	0.0007	CcSEcCtD
Glycopyrrolate—Dyspepsia—Triamcinolone—atopic dermatitis	0.000248	0.000696	CcSEcCtD
Glycopyrrolate—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000248	0.000694	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000247	0.000694	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000247	0.000694	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000247	0.000692	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000245	0.000687	CcSEcCtD
Glycopyrrolate—Urticaria—Prednisolone—atopic dermatitis	0.000243	0.000683	CcSEcCtD
Glycopyrrolate—Fatigue—Triamcinolone—atopic dermatitis	0.000243	0.000682	CcSEcCtD
Glycopyrrolate—Fatigue—Methylprednisolone—atopic dermatitis	0.000242	0.00068	CcSEcCtD
Glycopyrrolate—Pain—Triamcinolone—atopic dermatitis	0.000241	0.000676	CcSEcCtD
Glycopyrrolate—Hypotension—Dexamethasone—atopic dermatitis	0.000239	0.00067	CcSEcCtD
Glycopyrrolate—Hypotension—Betamethasone—atopic dermatitis	0.000239	0.00067	CcSEcCtD
Glycopyrrolate—Urticaria—Hydrocortisone—atopic dermatitis	0.000238	0.000667	CcSEcCtD
Glycopyrrolate—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000237	0.000664	CcSEcCtD
Glycopyrrolate—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000237	0.000664	CcSEcCtD
Glycopyrrolate—Convulsion—Prednisone—atopic dermatitis	0.000236	0.000663	CcSEcCtD
Glycopyrrolate—Hypertension—Prednisone—atopic dermatitis	0.000236	0.000661	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000232	0.000652	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000232	0.00065	CcSEcCtD
Glycopyrrolate—Insomnia—Betamethasone—atopic dermatitis	0.000231	0.000649	CcSEcCtD
Glycopyrrolate—Insomnia—Dexamethasone—atopic dermatitis	0.000231	0.000649	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000231	0.000647	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.00023	0.000645	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Prednisolone—atopic dermatitis	0.000226	0.000633	CcSEcCtD
Glycopyrrolate—Dyspepsia—Dexamethasone—atopic dermatitis	0.000225	0.000631	CcSEcCtD
Glycopyrrolate—Dyspepsia—Betamethasone—atopic dermatitis	0.000225	0.000631	CcSEcCtD
Glycopyrrolate—Urticaria—Triamcinolone—atopic dermatitis	0.000224	0.000628	CcSEcCtD
Glycopyrrolate—Urticaria—Methylprednisolone—atopic dermatitis	0.000223	0.000627	CcSEcCtD
Glycopyrrolate—Body temperature increased—Triamcinolone—atopic dermatitis	0.000223	0.000625	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Prednisone—atopic dermatitis	0.000223	0.000625	CcSEcCtD
Glycopyrrolate—Oedema—Prednisone—atopic dermatitis	0.000223	0.000625	CcSEcCtD
Glycopyrrolate—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000222	0.000624	CcSEcCtD
Glycopyrrolate—Infection—Prednisone—atopic dermatitis	0.000221	0.000621	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000221	0.000619	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000221	0.000619	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000221	0.000619	CcSEcCtD
Glycopyrrolate—Fatigue—Dexamethasone—atopic dermatitis	0.00022	0.000619	CcSEcCtD
Glycopyrrolate—Fatigue—Betamethasone—atopic dermatitis	0.00022	0.000619	CcSEcCtD
Glycopyrrolate—Pain—Dexamethasone—atopic dermatitis	0.000219	0.000613	CcSEcCtD
Glycopyrrolate—Pain—Betamethasone—atopic dermatitis	0.000219	0.000613	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Prednisone—atopic dermatitis	0.000218	0.000613	CcSEcCtD
Glycopyrrolate—Tachycardia—Prednisone—atopic dermatitis	0.000217	0.00061	CcSEcCtD
Glycopyrrolate—Skin disorder—Prednisone—atopic dermatitis	0.000216	0.000607	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Prednisone—atopic dermatitis	0.000215	0.000604	CcSEcCtD
Glycopyrrolate—Asthenia—Hydrocortisone—atopic dermatitis	0.000215	0.000602	CcSEcCtD
Glycopyrrolate—Pruritus—Hydrocortisone—atopic dermatitis	0.000212	0.000594	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000211	0.000591	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Betamethasone—atopic dermatitis	0.000211	0.000591	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000209	0.000587	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000209	0.000587	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000208	0.000583	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000207	0.000581	CcSEcCtD
Glycopyrrolate—Urticaria—Dexamethasone—atopic dermatitis	0.000203	0.00057	CcSEcCtD
Glycopyrrolate—Urticaria—Betamethasone—atopic dermatitis	0.000203	0.00057	CcSEcCtD
Glycopyrrolate—Dizziness—Prednisolone—atopic dermatitis	0.000203	0.000569	CcSEcCtD
Glycopyrrolate—Asthenia—Triamcinolone—atopic dermatitis	0.000202	0.000567	CcSEcCtD
Glycopyrrolate—Abdominal pain—Dexamethasone—atopic dermatitis	0.000202	0.000567	CcSEcCtD
Glycopyrrolate—Abdominal pain—Betamethasone—atopic dermatitis	0.000202	0.000567	CcSEcCtD
Glycopyrrolate—Body temperature increased—Dexamethasone—atopic dermatitis	0.000202	0.000567	CcSEcCtD
Glycopyrrolate—Body temperature increased—Betamethasone—atopic dermatitis	0.000202	0.000567	CcSEcCtD
Glycopyrrolate—Asthenia—Methylprednisolone—atopic dermatitis	0.000202	0.000566	CcSEcCtD
Glycopyrrolate—Insomnia—Prednisone—atopic dermatitis	0.000201	0.000565	CcSEcCtD
Glycopyrrolate—Pruritus—Triamcinolone—atopic dermatitis	0.000199	0.000559	CcSEcCtD
Glycopyrrolate—Pruritus—Methylprednisolone—atopic dermatitis	0.000199	0.000558	CcSEcCtD
Glycopyrrolate—Dizziness—Hydrocortisone—atopic dermatitis	0.000198	0.000555	CcSEcCtD
Glycopyrrolate—Dyspepsia—Prednisone—atopic dermatitis	0.000196	0.00055	CcSEcCtD
Glycopyrrolate—Rash—Prednisolone—atopic dermatitis	0.000193	0.000542	CcSEcCtD
Glycopyrrolate—Dermatitis—Prednisolone—atopic dermatitis	0.000193	0.000542	CcSEcCtD
Glycopyrrolate—Fatigue—Prednisone—atopic dermatitis	0.000192	0.000539	CcSEcCtD
Glycopyrrolate—Headache—Prednisolone—atopic dermatitis	0.000192	0.000539	CcSEcCtD
Glycopyrrolate—Constipation—Prednisone—atopic dermatitis	0.00019	0.000534	CcSEcCtD
Glycopyrrolate—Vomiting—Hydrocortisone—atopic dermatitis	0.00019	0.000534	CcSEcCtD
Glycopyrrolate—Rash—Hydrocortisone—atopic dermatitis	0.000189	0.000529	CcSEcCtD
Glycopyrrolate—Dermatitis—Hydrocortisone—atopic dermatitis	0.000189	0.000529	CcSEcCtD
Glycopyrrolate—Headache—Hydrocortisone—atopic dermatitis	0.000188	0.000526	CcSEcCtD
Glycopyrrolate—Dizziness—Triamcinolone—atopic dermatitis	0.000186	0.000523	CcSEcCtD
Glycopyrrolate—Dizziness—Methylprednisolone—atopic dermatitis	0.000186	0.000522	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Prednisone—atopic dermatitis	0.000184	0.000515	CcSEcCtD
Glycopyrrolate—Asthenia—Betamethasone—atopic dermatitis	0.000183	0.000515	CcSEcCtD
Glycopyrrolate—Asthenia—Dexamethasone—atopic dermatitis	0.000183	0.000515	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000182	0.000511	CcSEcCtD
Glycopyrrolate—Nausea—Prednisolone—atopic dermatitis	0.000182	0.000511	CcSEcCtD
Glycopyrrolate—Pruritus—Dexamethasone—atopic dermatitis	0.000181	0.000508	CcSEcCtD
Glycopyrrolate—Pruritus—Betamethasone—atopic dermatitis	0.000181	0.000508	CcSEcCtD
Glycopyrrolate—Vomiting—Triamcinolone—atopic dermatitis	0.000179	0.000503	CcSEcCtD
Glycopyrrolate—Vomiting—Methylprednisolone—atopic dermatitis	0.000179	0.000502	CcSEcCtD
Glycopyrrolate—Nausea—Hydrocortisone—atopic dermatitis	0.000178	0.000499	CcSEcCtD
Glycopyrrolate—Rash—Triamcinolone—atopic dermatitis	0.000178	0.000499	CcSEcCtD
Glycopyrrolate—Dermatitis—Triamcinolone—atopic dermatitis	0.000178	0.000498	CcSEcCtD
Glycopyrrolate—Rash—Methylprednisolone—atopic dermatitis	0.000177	0.000497	CcSEcCtD
Glycopyrrolate—Dermatitis—Methylprednisolone—atopic dermatitis	0.000177	0.000497	CcSEcCtD
Glycopyrrolate—Urticaria—Prednisone—atopic dermatitis	0.000177	0.000496	CcSEcCtD
Glycopyrrolate—Headache—Triamcinolone—atopic dermatitis	0.000177	0.000495	CcSEcCtD
Glycopyrrolate—Headache—Methylprednisolone—atopic dermatitis	0.000176	0.000494	CcSEcCtD
Glycopyrrolate—Abdominal pain—Prednisone—atopic dermatitis	0.000176	0.000494	CcSEcCtD
Glycopyrrolate—Body temperature increased—Prednisone—atopic dermatitis	0.000176	0.000494	CcSEcCtD
Glycopyrrolate—Dizziness—Betamethasone—atopic dermatitis	0.000169	0.000474	CcSEcCtD
Glycopyrrolate—Dizziness—Dexamethasone—atopic dermatitis	0.000169	0.000474	CcSEcCtD
Glycopyrrolate—Nausea—Triamcinolone—atopic dermatitis	0.000167	0.00047	CcSEcCtD
Glycopyrrolate—Nausea—Methylprednisolone—atopic dermatitis	0.000167	0.000469	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Prednisone—atopic dermatitis	0.000164	0.00046	CcSEcCtD
Glycopyrrolate—Vomiting—Dexamethasone—atopic dermatitis	0.000163	0.000456	CcSEcCtD
Glycopyrrolate—Vomiting—Betamethasone—atopic dermatitis	0.000163	0.000456	CcSEcCtD
Glycopyrrolate—Rash—Dexamethasone—atopic dermatitis	0.000161	0.000452	CcSEcCtD
Glycopyrrolate—Rash—Betamethasone—atopic dermatitis	0.000161	0.000452	CcSEcCtD
Glycopyrrolate—Dermatitis—Dexamethasone—atopic dermatitis	0.000161	0.000452	CcSEcCtD
Glycopyrrolate—Dermatitis—Betamethasone—atopic dermatitis	0.000161	0.000452	CcSEcCtD
Glycopyrrolate—Headache—Dexamethasone—atopic dermatitis	0.00016	0.000449	CcSEcCtD
Glycopyrrolate—Headache—Betamethasone—atopic dermatitis	0.00016	0.000449	CcSEcCtD
Glycopyrrolate—Asthenia—Prednisone—atopic dermatitis	0.00016	0.000448	CcSEcCtD
Glycopyrrolate—Pruritus—Prednisone—atopic dermatitis	0.000158	0.000442	CcSEcCtD
Glycopyrrolate—Nausea—Betamethasone—atopic dermatitis	0.000152	0.000426	CcSEcCtD
Glycopyrrolate—Nausea—Dexamethasone—atopic dermatitis	0.000152	0.000426	CcSEcCtD
Glycopyrrolate—Dizziness—Prednisone—atopic dermatitis	0.000147	0.000413	CcSEcCtD
Glycopyrrolate—Vomiting—Prednisone—atopic dermatitis	0.000142	0.000397	CcSEcCtD
Glycopyrrolate—Rash—Prednisone—atopic dermatitis	0.00014	0.000394	CcSEcCtD
Glycopyrrolate—Dermatitis—Prednisone—atopic dermatitis	0.00014	0.000394	CcSEcCtD
Glycopyrrolate—Headache—Prednisone—atopic dermatitis	0.00014	0.000391	CcSEcCtD
Glycopyrrolate—Nausea—Prednisone—atopic dermatitis	0.000132	0.000371	CcSEcCtD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL17—atopic dermatitis	7.57e-05	0.00209	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—CCR5—atopic dermatitis	7.57e-05	0.00209	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL17—atopic dermatitis	7.5e-05	0.00207	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL27—atopic dermatitis	7.42e-05	0.00205	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CCR3—atopic dermatitis	7.4e-05	0.00204	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	7.29e-05	0.00201	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—TAC1—atopic dermatitis	7.26e-05	0.00201	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—NPS—atopic dermatitis	7.26e-05	0.00201	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CXCR3—atopic dermatitis	7.12e-05	0.00197	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL27—atopic dermatitis	7.1e-05	0.00196	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCR3—atopic dermatitis	7.09e-05	0.00196	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	7e-05	0.00193	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	6.99e-05	0.00193	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.97e-05	0.00193	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—NPS—atopic dermatitis	6.96e-05	0.00192	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—TAC1—atopic dermatitis	6.96e-05	0.00192	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.91e-05	0.00191	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CXCL10—atopic dermatitis	6.87e-05	0.0019	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CXCL10—atopic dermatitis	6.85e-05	0.00189	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CXCR3—atopic dermatitis	6.82e-05	0.00188	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CXCL10—atopic dermatitis	6.78e-05	0.00187	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—IL5—atopic dermatitis	6.75e-05	0.00186	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL17—atopic dermatitis	6.65e-05	0.00184	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—TAC1—atopic dermatitis	6.6e-05	0.00182	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—NPS—atopic dermatitis	6.6e-05	0.00182	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CXCR3—atopic dermatitis	6.47e-05	0.00179	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—IL5—atopic dermatitis	6.47e-05	0.00179	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL17—atopic dermatitis	6.37e-05	0.00176	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—TAC1—atopic dermatitis	6.32e-05	0.00174	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—NPS—atopic dermatitis	6.32e-05	0.00174	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.27e-05	0.00173	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CXCR3—atopic dermatitis	6.2e-05	0.00171	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL5—atopic dermatitis	6.13e-05	0.00169	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCL11—atopic dermatitis	6.12e-05	0.00169	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL11—atopic dermatitis	6.1e-05	0.00168	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL11—atopic dermatitis	6.04e-05	0.00167	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FCER2—atopic dermatitis	6.04e-05	0.00167	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FCER2—atopic dermatitis	6.02e-05	0.00166	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.01e-05	0.00166	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FCER2—atopic dermatitis	5.96e-05	0.00165	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—KIF3A—atopic dermatitis	5.93e-05	0.00164	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CCL5—atopic dermatitis	5.91e-05	0.00163	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CCL5—atopic dermatitis	5.9e-05	0.00163	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL5—atopic dermatitis	5.87e-05	0.00162	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CCL5—atopic dermatitis	5.84e-05	0.00161	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CXCL10—atopic dermatitis	5.76e-05	0.00159	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GLB1—atopic dermatitis	5.69e-05	0.00157	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—KIF3A—atopic dermatitis	5.68e-05	0.00157	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL22—atopic dermatitis	5.61e-05	0.00155	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL22—atopic dermatitis	5.59e-05	0.00154	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL22—atopic dermatitis	5.54e-05	0.00153	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CXCL10—atopic dermatitis	5.51e-05	0.00152	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CCR3—atopic dermatitis	5.5e-05	0.00152	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CCR3—atopic dermatitis	5.48e-05	0.00151	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ADSL—atopic dermatitis	5.45e-05	0.00151	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CCR3—atopic dermatitis	5.42e-05	0.0015	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL11—atopic dermatitis	5.36e-05	0.00148	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CMA1—atopic dermatitis	5.36e-05	0.00148	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CCR5—atopic dermatitis	5.33e-05	0.00147	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CCR5—atopic dermatitis	5.31e-05	0.00147	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—MAPK8—atopic dermatitis	5.3e-05	0.00146	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CCR5—atopic dermatitis	5.26e-05	0.00145	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—CXCL8—atopic dermatitis	5.25e-05	0.00145	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CXCL10—atopic dermatitis	5.23e-05	0.00144	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CMA1—atopic dermatitis	5.14e-05	0.00142	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL11—atopic dermatitis	5.14e-05	0.00142	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	5.07e-05	0.0014	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—STAT6—atopic dermatitis	5.04e-05	0.00139	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CXCL10—atopic dermatitis	5.01e-05	0.00138	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	5e-05	0.00138	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	4.99e-05	0.00138	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL27—atopic dermatitis	4.99e-05	0.00138	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCR3—atopic dermatitis	4.97e-05	0.00137	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CCL5—atopic dermatitis	4.96e-05	0.00137	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	4.94e-05	0.00136	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	4.93e-05	0.00136	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	4.9e-05	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	4.9e-05	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—TAC1—atopic dermatitis	4.88e-05	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—NPS—atopic dermatitis	4.88e-05	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	4.84e-05	0.00134	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	4.84e-05	0.00134	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—STAT6—atopic dermatitis	4.83e-05	0.00133	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	4.8e-05	0.00133	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCR3—atopic dermatitis	4.79e-05	0.00132	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—CXCL8—atopic dermatitis	4.78e-05	0.00132	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CCL5—atopic dermatitis	4.75e-05	0.00131	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	4.74e-05	0.00131	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—CXCL8—atopic dermatitis	4.58e-05	0.00126	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	4.56e-05	0.00126	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	4.55e-05	0.00126	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—IL5—atopic dermatitis	4.54e-05	0.00125	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CCL5—atopic dermatitis	4.5e-05	0.00124	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	4.5e-05	0.00124	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	4.49e-05	0.00124	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL17—atopic dermatitis	4.47e-05	0.00123	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CCR5—atopic dermatitis	4.47e-05	0.00123	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	4.45e-05	0.00123	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	4.45e-05	0.00123	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—TAC1—atopic dermatitis	4.43e-05	0.00122	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—NPS—atopic dermatitis	4.43e-05	0.00122	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	4.43e-05	0.00122	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	4.39e-05	0.00121	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	4.39e-05	0.00121	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCR3—atopic dermatitis	4.37e-05	0.00121	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	4.36e-05	0.0012	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCR3—atopic dermatitis	4.35e-05	0.0012	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCL5—atopic dermatitis	4.31e-05	0.00119	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	4.31e-05	0.00119	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CCR5—atopic dermatitis	4.28e-05	0.00118	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.23e-05	0.00117	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.22e-05	0.00116	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCR3—atopic dermatitis	4.19e-05	0.00116	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.18e-05	0.00115	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	4.14e-05	0.00114	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL5—atopic dermatitis	4.12e-05	0.00114	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	4.09e-05	0.00113	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	4.08e-05	0.00113	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CCR5—atopic dermatitis	4.06e-05	0.00112	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	4e-05	0.0011	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KIF3A—atopic dermatitis	3.99e-05	0.0011	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	3.95e-05	0.00109	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NPS—atopic dermatitis	3.9e-05	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TAC1—atopic dermatitis	3.9e-05	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCR5—atopic dermatitis	3.88e-05	0.00107	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	3.88e-05	0.00107	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCL10—atopic dermatitis	3.87e-05	0.00107	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	3.83e-05	0.00106	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCR3—atopic dermatitis	3.82e-05	0.00106	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TAC1—atopic dermatitis	3.73e-05	0.00103	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NPS—atopic dermatitis	3.73e-05	0.00103	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCR3—atopic dermatitis	3.66e-05	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL5—atopic dermatitis	3.62e-05	0.001	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	3.62e-05	0.000999	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	3.62e-05	0.000999	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CMA1—atopic dermatitis	3.6e-05	0.000995	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL11—atopic dermatitis	3.6e-05	0.000995	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	3.57e-05	0.000986	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	3.57e-05	0.000986	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	3.53e-05	0.000974	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL10—atopic dermatitis	3.51e-05	0.00097	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	3.48e-05	0.000961	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL5—atopic dermatitis	3.47e-05	0.000958	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	3.4e-05	0.000939	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—STAT6—atopic dermatitis	3.39e-05	0.000936	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	3.39e-05	0.000935	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	3.36e-05	0.000927	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	3.34e-05	0.000923	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CCL5—atopic dermatitis	3.33e-05	0.00092	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	3.3e-05	0.000911	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	3.22e-05	0.000889	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CXCL8—atopic dermatitis	3.21e-05	0.000887	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.21e-05	0.000886	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.2e-05	0.000883	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	3.18e-05	0.000878	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL10—atopic dermatitis	3.09e-05	0.000853	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	3.04e-05	0.000838	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL5—atopic dermatitis	3.03e-05	0.000835	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	3.01e-05	0.000831	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CCR5—atopic dermatitis	3e-05	0.000829	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	3e-05	0.000827	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	2.97e-05	0.000821	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL10—atopic dermatitis	2.96e-05	0.000817	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	2.95e-05	0.000814	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR3—atopic dermatitis	2.94e-05	0.000811	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	2.91e-05	0.000804	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	2.73e-05	0.000755	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	2.73e-05	0.000753	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CXCL8—atopic dermatitis	2.7e-05	0.000745	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	2.7e-05	0.000745	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL5—atopic dermatitis	2.66e-05	0.000734	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NPS—atopic dermatitis	2.63e-05	0.000726	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	2.63e-05	0.000726	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NPS—atopic dermatitis	2.62e-05	0.000723	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	2.62e-05	0.000723	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NPS—atopic dermatitis	2.59e-05	0.000716	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	2.59e-05	0.000716	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	2.59e-05	0.000714	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—IL2—atopic dermatitis	2.58e-05	0.000712	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	2.58e-05	0.000711	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	2.57e-05	0.000709	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL5—atopic dermatitis	2.55e-05	0.000703	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	2.54e-05	0.000702	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—IL2—atopic dermatitis	2.47e-05	0.000682	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NGF—atopic dermatitis	2.46e-05	0.00068	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CXCL8—atopic dermatitis	2.45e-05	0.000677	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL5—atopic dermatitis	2.44e-05	0.000674	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL5—atopic dermatitis	2.44e-05	0.000672	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL5—atopic dermatitis	2.41e-05	0.000666	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	2.4e-05	0.000661	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NGF—atopic dermatitis	2.36e-05	0.000651	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	2.35e-05	0.000648	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	2.34e-05	0.000647	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	2.29e-05	0.000633	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	2.24e-05	0.00062	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	2.08e-05	0.000575	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	2.08e-05	0.000573	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	2.06e-05	0.000568	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	2.03e-05	0.000561	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	1.94e-05	0.000537	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPARA—atopic dermatitis	1.85e-05	0.00051	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.82e-05	0.000503	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.81e-05	0.000501	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.8e-05	0.000496	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	1.79e-05	0.000495	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	1.79e-05	0.000493	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	1.77e-05	0.000489	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	1.74e-05	0.00048	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	1.73e-05	0.000479	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	1.72e-05	0.000474	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NGF—atopic dermatitis	1.66e-05	0.000458	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NGF—atopic dermatitis	1.66e-05	0.000457	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	1.65e-05	0.000456	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	1.65e-05	0.000455	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NGF—atopic dermatitis	1.64e-05	0.000453	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	1.63e-05	0.000451	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	1.62e-05	0.000446	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	1.61e-05	0.000445	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	1.59e-05	0.00044	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	1.58e-05	0.000436	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	1.57e-05	0.000435	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	1.56e-05	0.000431	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	1.45e-05	0.0004	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	1.39e-05	0.000383	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL2—atopic dermatitis	1.38e-05	0.000382	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	1.38e-05	0.00038	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	1.37e-05	0.000378	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	1.37e-05	0.000377	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	1.35e-05	0.000373	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL2—atopic dermatitis	1.33e-05	0.000366	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	1.32e-05	0.000364	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	1.27e-05	0.000352	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	1.22e-05	0.000337	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	9.77e-06	0.00027	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	9.73e-06	0.000269	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	9.64e-06	0.000266	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL2—atopic dermatitis	9.33e-06	0.000258	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL2—atopic dermatitis	9.3e-06	0.000257	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	9.29e-06	0.000256	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	9.26e-06	0.000256	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL2—atopic dermatitis	9.21e-06	0.000254	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	9.17e-06	0.000253	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	8.59e-06	0.000237	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	8.56e-06	0.000236	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	8.48e-06	0.000234	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6—atopic dermatitis	8.14e-06	0.000225	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6—atopic dermatitis	7.79e-06	0.000215	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6—atopic dermatitis	5.49e-06	0.000151	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6—atopic dermatitis	5.47e-06	0.000151	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6—atopic dermatitis	5.42e-06	0.00015	CbGpPWpGaD
